Letters: Hasty ban

Image
Business Standard New Delhi
Last Updated : Mar 20 2016 | 10:11 PM IST
The phrase "knee-jerk reaction" used in the editorial dated March 18 rightly summarises the approach of the Union ministry of health and family welfare to the issue of fixed dose combinations. The Kokate Committee had done a scientific and thorough job of delineating this issue. However, the botch-up has been in the implementation of this report by the bureaucrats. This commercially sensitive issue has not been discussed properly by the authorities concerned. Nor has the industry been able to digest the show-cause approach. After the expert committee furnished its report, at least the relevant portions should have been made public first, and the ministry should have taken the industry into confidence and discussed the matter threadbare at various platforms.

There was no tearing hurry to impose a ban on the combination drugs. After all, the permission to market them was provided by the Union or state governments themselves. The ministry should have created a blueprint in consultation with all the stakeholders concerned to phase out the drugs or once again approve them based on new clinical data. Let us remember that there are companies whose survival is at stake and several jobs are on the chopping block due to the knee-jerk reaction.
Sunil S Chiplunkar, Bengaluru

Letters can be mailed, faxed or e-mailed to:
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg
New Delhi 110 002
Fax: (011) 23720201 · E-mail: letters@bsmail.in
All letters must have a postal address and telephone number
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 20 2016 | 9:36 PM IST

Next Story